Find Grants for Native American & Tribal Governments
Find out if you qualify for verified grants for Native American & Tribal Governments. Discover your eligibility and key funding details for Native American & Tribal Governments from major foundations and government agencies.
Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)
Deadline: December 23, 2027
Opportunity Number: RFA-HL-26-017
Agency: National Institutes of Health
Open Date: November 22, 2024
Close Date: December 23, 2027
Status: Posted
CFDA Numbers: 93.839, 93.838, 93.233, 93.837
Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allowed)
Deadline: December 23, 2027
Opportunity Number: RFA-HL-26-018
Agency: National Institutes of Health
Open Date: November 22, 2024
Close Date: December 23, 2027
Status: Posted
CFDA Numbers: 93.839, 93.233, 93.838, 93.837
Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional)
Deadline: January 7, 2028
Opportunity Number: PAR-25-281
Agency: National Institutes of Health
Open Date: November 22, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.242, 93.313
Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional)
Deadline: January 7, 2028
Opportunity Number: PAR-25-282
Agency: National Institutes of Health
Open Date: November 22, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.242, 93.313
Occupational Safety and Health Training Project Grants (T03)
Deadline: October 26, 2028
Opportunity Number: RFA-OH-25-003
Agency: Centers for Disease Control and Prevention - ERA
Open Date: November 22, 2024
Close Date: October 26, 2028
Status: Posted
CFDA Numbers: 93.262
Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)
Deadline: November 19, 2026
Opportunity Number: PAR-25-226
Agency: National Institutes of Health
Open Date: November 22, 2024
Close Date: November 19, 2026
Status: Posted
CFDA Numbers: 93.242
Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R01 Clinical Trial Optional)
Deadline: January 7, 2028
Opportunity Number: PAR-25-290
Agency: National Institutes of Health
Open Date: November 22, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.242
Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional)
Deadline: January 7, 2028
Opportunity Number: PAR-25-291
Agency: National Institutes of Health
Open Date: November 22, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.242
Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
Deadline: January 7, 2028
Opportunity Number: PAR-25-148
Agency: National Institutes of Health
Open Date: November 21, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.396, 93.865, 93.866, 93.393, 93.395, 93.173, 93.394, 93.172, 93.273, 93.242, 93.279, 93.839, 93.867, 93.840, 93.837, 93.361, 93.233, 93.838, 93.399
BRAIN Initiative: Promoting Health for All Through BRAIN Technology Partnerships (R34 - Clinical Trials Not Allowed)
Deadline: June 17, 2026
Opportunity Number: RFA-NS-25-016
Agency: National Institutes of Health
Open Date: November 21, 2024
Close Date: June 17, 2026
Status: Posted
CFDA Numbers: 93.173, 93.866, 93.273, 93.853, 93.286, 93.279, 93.867, 93.242, 93.213, 93.865
Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)
Deadline: November 17, 2026
Opportunity Number: PAR-25-274
Agency: National Institutes of Health
Open Date: November 21, 2024
Close Date: November 17, 2026
Status: Posted
CFDA Numbers: 93.213
Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed)
Deadline: May 4, 2026
Opportunity Number: PAR-25-106
Agency: National Institutes of Health
Open Date: November 21, 2024
Close Date: May 4, 2026
Status: Posted
CFDA Numbers: 93.394, 93.395
Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)
Deadline: November 17, 2026
Opportunity Number: PAR-25-268
Agency: National Institutes of Health
Open Date: November 21, 2024
Close Date: November 17, 2026
Status: Posted
CFDA Numbers: 93.213
Limited Competition: Competing Revisions to Support Clinical Trials in Somatic Cell Genome Editing (U19 Clinical Trial Required)
Deadline: February 13, 2026
Opportunity Number: RFA-RM-24-008
Agency: National Institutes of Health
Open Date: November 21, 2024
Close Date: February 13, 2026
Status: Posted
CFDA Numbers: 93.310
NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required)
Deadline: November 17, 2026
Opportunity Number: PAR-25-267
Agency: National Institutes of Health
Open Date: November 21, 2024
Close Date: November 17, 2026
Status: Posted
CFDA Numbers: 93.213
Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R01 Clinical Trial Not Allowed)
Deadline: January 7, 2028
Opportunity Number: PAR-25-287
Agency: National Institutes of Health
Open Date: November 21, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.242
Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed)
Deadline: January 7, 2028
Opportunity Number: PAR-25-286
Agency: National Institutes of Health
Open Date: November 21, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.242
Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional)
Deadline: January 7, 2027
Opportunity Number: PAR-25-235
Agency: National Institutes of Health
Open Date: November 21, 2024
Close Date: January 7, 2027
Status: Posted
CFDA Numbers: 93.242, 93.879
Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities (R01, Clinical Trial Required)
Deadline: May 7, 2027
Opportunity Number: PAR-26-001
Agency: National Institutes of Health
Open Date: November 21, 2024
Close Date: May 7, 2027
Status: Posted
CFDA Numbers: 93.307, 93.273, 93.399, 93.121, 93.279, 93.313
Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required)
Deadline: May 7, 2026
Opportunity Number: PAR-25-254
Agency: National Institutes of Health
Open Date: November 21, 2024
Close Date: May 7, 2026
Status: Posted
CFDA Numbers: 93.399
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)
Deadline: October 8, 2027
Opportunity Number: PAR-25-248
Agency: National Institutes of Health
Open Date: November 21, 2024
Close Date: October 8, 2027
Status: Posted
CFDA Numbers: 93.393
Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)
Deadline: November 18, 2027
Opportunity Number: RFA-DA-26-034
Agency: National Institutes of Health
Open Date: November 20, 2024
Close Date: November 18, 2027
Status: Posted
CFDA Numbers: 93.839, 93.837, 93.840, 93.855, 93.233, 93.279, 93.838
NCI Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed)
Deadline: October 14, 2027
Opportunity Number: PAR-25-135
Agency: National Institutes of Health
Open Date: November 20, 2024
Close Date: October 14, 2027
Status: Posted
CFDA Numbers: 93.398
NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)
Deadline: November 19, 2026
Opportunity Number: PAR-25-052
Agency: National Institutes of Health
Open Date: November 20, 2024
Close Date: November 19, 2026
Status: Posted
CFDA Numbers: 93.853
Advancement and Innovation in Measurement of Language Development and Predictors (R01 Clinical Trial Not Allowed)
Deadline: September 7, 2027
Opportunity Number: PAR-25-112
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: September 7, 2027
Status: Posted
CFDA Numbers: 93.865, 93.173
